QuestDB Supports HDFC Bank’s Real-Time Transaction Monitoring and Risk Analytics Vistin Pharma ASA: Fourth quarter and preliminary 2020 financial results
Oslo, Norway, 19th of February 2021 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces…
Immunicum AB (publ) Receives Orphan Drug Designation from EMA for Ilixadencel as Treatment for Gastrointestinal Stromal Tumors (GIST)
Press Release 19 February 2021 Immunicum AB (publ) Receives Orphan Drug Designation from EMA for…
Travere Therapeutics Announces European Commission Has Granted Orphan Designation to Sparsentan for the Treatment of IgA Nephropathy
SAN DIEGO, Feb. 18, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
Harvard Bioscience Schedules Fourth Quarter 2020 Earnings Conference Call for March 10, 2021 at 8:00 AM ET
HOLLISTON, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce…
Junshi Biosciences Announces Acceptance by the NMPA of Supplemental New Drug Application for Toripalimab Combined with Chemotherapy for The First-Line Treatment of Nasopharyngeal Carcinoma
–the 3rd sNDA for Toripalimab in China SHANGHAI, China, Feb. 19, 2021 (GLOBE NEWSWIRE) —…
MacroGenics Announces Date of Fourth Quarter and Full Year 2020 Financial Results Conference Call
ROCKVILLE, MD, Feb. 18, 2021 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical…
Osmotica to Present at 10th Annual SVB Leerink Global Healthcare Conference
BRIDGEWATER, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or…
Codexis to Present at Upcoming Virtual Healthcare Conferences
REDWOOD CITY, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading enzyme…
Apellis Pharmaceuticals to Hold Fourth Quarter and Full Year 2020 Earnings Conference Call on February 25, 2021
WALTHAM, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical…
Technology and Health Leaders Join Myriad Genetics, Advance in Senior Roles to Drive Key Enterprise Functions, Transformation and Growth Initiatives
New talent and promotions span core businesses, transformation, IT, revenue cycle management, business development, marketing,…
Diffusion Pharmaceuticals Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares of Common Stock
CHARLOTTESVILLE, Va., Feb. 18, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the…
Caladrius Biosciences to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Thursday, February 25, 2021 at 4:30 p.m. Eastern Time
BASKING RIDGE, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius”…
Ascendis Pharma A/S Announces Participation at SVB Leerink 10th Annual Global Healthcare Conference
COPENHAGEN, Denmark, Feb. 18, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…
Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine
Advances joint commitment from Novavax, Serum Institute of India and Gavi to ensure equitable access…
Trevi Therapeutics to Present at 10th Annual SVB Leerink Global Healthcare Conference
NEW HAVEN, Conn., Feb. 18, 2021 (GLOBE NEWSWIRE) — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a…
Cambium Networks Reports Fourth Quarter and Full Year 2020 Financial Results
Record revenues of $82.8 million, increased 13% sequentially, up 29% year-over-year Gross margin of 51.0%,…
Larimar Therapeutics to Present at the SVB Leerink 10th Annual Global Healthcare Conference
BALA CYNWYD, Pa., Feb. 18, 2021 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…
Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2020 Results and Corporate Update
CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome…
Cara Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
STAMFORD, Conn., Feb. 18, 2021 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company…
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results After the Close of Markets on Thursday, March 11, 2021
LAKE FOREST, Ill., Feb. 18, 2021 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…